José Rocha

Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

Luís Almeida, José Rocha, Amílcar Falcão et al. · Clinical Pharmacokinetics · 2012 · 86 citations

Healthy Subjects, Novel Catechol-o-methyltransferase Inhibitor, Active Ingredient +4

Opicapone: a short lived and very long acting novel catechol‐<scp>O</scp>‐methyltransferase inhibitor following multiple dose administration in healthy subjects

José Rocha, Luís Almeida, Amílcar Falcão et al. · British Journal of Clinical Pharmacology · 2013 · 85 citations · Full text

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase <scp>III</scp> double‐blind, randomized, parallel‐group, multicenter study

Eugen Trinka, Elinor Ben‐Menachem, Pedro André Kowacs et al. · Epilepsia · 2018 · 83 citations · Full text

Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers

Teresa Nunes, José Rocha, Amílcar Falcão et al. · Epilepsia · 2012 · 74 citations

Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials

Victor Biton, Joanne Rogin, Gregory L. Krauss et al. · Epilepsy & Behavior · 2017 · 47 citations · Full text